LMNA Knock-Down Affects Differentiation and Progression of Human Neuroblastoma Cells

Background Neuroblastoma (NB) is one of the most aggressive tumors that occur in childhood. Although genes, such as MYCN, have been shown to be involved in the aggressiveness of the disease, the identification of new biological markers is still desirable. The induction of differentiation is one of the strategies used in the treatment of neuroblastoma. A-type lamins are components of the nuclear lamina and are involved in differentiation. We studied the role of Lamin A/C in the differentiation and progression of neuroblastoma. Methodology/Principal Findings Knock-down of Lamin A/C (LMNA-KD) in neuroblastoma cells blocked retinoic acid-induced differentiation, preventing neurites outgrowth and the expression of neural markers. The genome-wide gene-expression profile and the proteomic analysis of LMNA-KD cells confirmed the inhibition of differentiation and demonstrated an increase of aggressiveness-related genes and molecules resulting in augmented migration/invasion, and increasing the drug resistance of the cells. The more aggressive phenotype acquired by LMNA-KD cells was also maintained in vivo after injection into nude mice. A preliminary immunohistochemistry analysis of Lamin A/C expression in nine primary stages human NB indicated that this protein is poorly expressed in most of these cases. Conclusions/Significance We demonstrated for the first time in neuroblastoma cells that Lamin A/C plays a central role in the differentiation, and that the loss of this protein gave rise to a more aggressive tumor phenotype.

[1]  E. van den Berg,et al.  Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence. , 2011, European journal of cancer.

[2]  A. Godwin,et al.  Chinese Anti鄄 Cancer a Ssociation , 2011 .

[3]  A. Godwin,et al.  Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer , 2011, BMC medicine.

[4]  Jesse D. Martinez,et al.  14-3-3γ Induces Oncogenic Transformation by Stimulating MAP Kinase and PI3K Signaling , 2010, PloS one.

[5]  X. Tong,et al.  Expression of the Actin-binding Proteins Indicates that Cofilin and Fascin are Related to Breast Tumour Size , 2010, The Journal of international medical research.

[6]  P. Fisher,et al.  Molecular mechanism of chemoresistance by astrocyte elevated gene-1. , 2010, Cancer research.

[7]  R. Boldrini,et al.  NF-kappaB, and not MYCN, regulates MHC class I and endoplasmic reticulum aminopeptidases in human neuroblastoma cells. , 2010, Cancer research.

[8]  V. Andrés,et al.  Role of A-type lamins in signaling, transcription, and chromatin organization , 2009, The Journal of cell biology.

[9]  E. Meshorer,et al.  Nuclear lamins: key regulators of nuclear structure and activities , 2009, Journal of cellular and molecular medicine.

[10]  Hua Guo,et al.  14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival. , 2009, Cancer research.

[11]  K. S. Egorova,et al.  The B-type lamin is required for somatic repression of testis-specific gene clusters , 2009, Proceedings of the National Academy of Sciences.

[12]  Hitoshi Tsuda,et al.  Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance , 2009, Modern Pathology.

[13]  Dazhi Xu,et al.  Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma , 2009, Journal of experimental & clinical cancer research : CR.

[14]  E. C. Schirmer.  The epigenetics of nuclear envelope organization and disease. , 2008, Mutation research.

[15]  P. van Endert,et al.  Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non‐lymphoid human tissues , 2008, Journal of cellular physiology.

[16]  S. Hirohashi,et al.  Expression and Gene Amplification of Actinin-4 in Invasive Ductal Carcinoma of the Pancreas , 2008, Clinical Cancer Research.

[17]  P. A. van den Brandt,et al.  Lamin A/C Is a Risk Biomarker in Colorectal Cancer , 2008, PloS one.

[18]  E. Bertolino,et al.  Transcriptional repression mediated by repositioning of genes to the nuclear lamina , 2008, Nature.

[19]  Yiider Tseng,et al.  Nuclear lamin A/C deficiency induces defects in cell mechanics, polarization, and migration. , 2007, Biophysical journal.

[20]  S. Påhlman,et al.  Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation. , 2007, Seminars in cancer biology.

[21]  W. Wahli,et al.  Guiding Ligands to Nuclear Receptors , 2007, Cell.

[22]  R. Foisner,et al.  A-type lamin networks in light of laminopathic diseases. , 2007, Biochimica et biophysica acta.

[23]  R. Foisner,et al.  Nucleoplasmic lamins and their interaction partners, LAP2α, Rb, and BAF, in transcriptional regulation , 2007, The FEBS journal.

[24]  Richard L. Frock,et al.  Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. , 2006, Genes & development.

[25]  D. Ribatti,et al.  Bcl‐2 overexpression in melanoma cells increases tumor progression‐associated properties and in vivo tumor growth , 2005, Journal of cellular physiology.

[26]  R. Andersen,et al.  Strongylophorine-26, a Rho-dependent inhibitor of tumor cell invasion that reduces actin stress fibers and induces nonpolarized lamellipodial extensions , 2005, Molecular Cancer Therapeutics.

[27]  F. Mami-Chouaib,et al.  Mutant α-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinoma , 2004, Oncogene.

[28]  G. Brodeur.  Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.

[29]  R. Trembath,et al.  A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. , 2002, Human molecular genetics.

[30]  D. Stram,et al.  International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors , 2001, Cancer.

[31]  M. Mena,et al.  Functional implications of the noradrenergic‐cholinergic switch induced by retinoic acid in NB69 neuroblastoma cells , 2000, Journal of neuroscience research.

[32]  A. Evans,et al.  The human non-muscle α-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells , 2000, Oncogene.

[33]  Hiroyuki Shimada,et al.  Terminology and morphologic criteria of neuroblastic tumors , 1999, Cancer.

[34]  H. Worman,et al.  Expression of nuclear lamins in human tissues and cancer cell lines and transcription from the promoters of the lamin A/C and B1 genes. , 1997, Experimental cell research.

[35]  D. Ellis,et al.  GST-lamin fusion proteins act as dominant negative mutants in Xenopus egg extract and reveal the function of the lamina in DNA replication. , 1997, Journal of cell science.

[36]  S. Piñol-Roma.  HnRNP proteins and the nuclear export of mRNA. , 1997, Seminars in cell & developmental biology.

[37]  K Weber,et al.  Expression of Drosophila lamin C is developmentally regulated: analogies with vertebrate A-type lamins. , 1995, Journal of cell science.

[38]  K. Weber,et al.  Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. , 1989, Development.

[39]  H. Sather,et al.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.

[40]  G. Schatten,et al.  Nuclear lamins and peripheral nuclear antigens during fertilization and embryogenesis in mice and sea urchins. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Hausen,et al.  Changes in the nuclear lamina composition during early development of Xenopus laevis , 1985, Cell.

[42]  W. Franke,et al.  Cell type-specific expression of nuclear lamina proteins during development of Xenopus laevis , 1985, Cell.

[43]  R. Goldman,et al.  Nuclear lamins: building blocks of nuclear structure and function. , 2005, Novartis Foundation symposium.

[44]  Richard T. Lee,et al.  The nuclear membrane and mechanotransduction: impaired nuclear mechanics and mechanotransduction in lamin A/C deficient cells. , 2005, Novartis Foundation symposium.

[45]  F. Mami-Chouaib,et al.  Mutant alpha-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinoma. , 2004, Oncogene.